JohnASchirgerMD
Cardiology • La Crosse, WIAdult Congenital Heart Disease, Heart Failure & Transplantation
Assistant Professor, Family Medicine, Mayo Medical School
Dr. Schirger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 West Ave S
La Crosse, WI 54601Phone+1 608-785-0940Fax+1 507-255-3125
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2002 - 2008- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1999 - 2002
Creighton University School of MedicineClass of 1999
Certifications & Licensure
MN State Medical License 2000 - 2025
WI State Medical License 2014 - 2025
OH State Medical License 2020 - 2024
AZ State Medical License 2017 - 2022
FL State Medical License 2017 - 2019- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction Start of enrollment: 2014 Jan 01
- Safety Study of Chimeric Natriuretic Peptide(CD-NP) in Stable LVAD Patients Start of enrollment: 2013 Apr 01
- CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- 58 citationsDonor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound ...Yan Topilsky, Manish J. Gandhi, Tal Hasin, Laurie Voit, Eugenia Raichlin
Transplantation. 2013-01-27 - 83 citationsEchocardiographic variables after left ventricular assist device implantation associated with adverse outcome.Yan Topilsky, Tal Hasin, Jae K. Oh, Daniel D. Borgeson, Barry A. Boilson
Circulation. Cardiovascular Imaging. 2011-11-01 - 85 citationsEchocardiographic Predictors of Adverse Outcomes After Continuous Left Ventricular Assist Device ImplantationYan Topilsky, Jae K. Oh, Dipesh K. Shah, Barry A. Boilson, John A. Schirger
JACC. Cardiovascular Imaging. 2011-03-01
Authored Content
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Join now to see all
Press Mentions
Trinity Health System Expands Structural Heart ProgramSeptember 7th, 2022- Trinity Health System in Steubenville Launches New Heart Valve ProcedureMay 15th, 2021
Catholic Medical Association Issues Support of the Palliative Care and Hospice Education and Training ActSeptember 23rd, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
